The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective

Published:2022-04-07 Issue:6 Volume:63 Page:819-822
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Lee Sze Ting,Emmett Louise M.,Pattison David A.,Hofman Michael S.,Bailey Dale L.,Latter Melissa J.,Francis Roslyn J.,Scott Andrew M.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference8 articles.

1. Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

2. [ 177 Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study

3. [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial;Hofman;Lancet.,2021

4. Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

5. ENETS consensus guidelines for the standards of care in neuroendocrine neoplasia: peptide receptor radionuclide therapy with radiolabeled somatostatin analogues;Hicks;Neuroendocrinology.,2017

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Theranostics and molecular imaging training in the arab world: present and prospects;European Journal of Nuclear Medicine and Molecular Imaging;2024-07-15

2. Radiotheranostics Global Market and Future Developments;Seminars in Nuclear Medicine;2024-07

3. Production and regulatory issues for theranostics;The Lancet Oncology;2024-06

4. Trends in nuclear medicine and the radiopharmaceutical sciences in oncology: workforce challenges and training in the age of theranostics;The Lancet Oncology;2024-06

5. Theranostics: Timing is Everything;Cancer Biotherapy and Radiopharmaceuticals;2024-05-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3